Article info

Download PDFPDF

Is it currently reasonable to offer short, 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?
Free

Authors

  • Guillaume Coiffier Rhumatologie, CHU de Rennes, Rennes, France Osteoarticular Infections Working Group of the French Society of Rheumatology, Paris, France PubMed articlesGoogle scholar articles
  • Marion Couderc Osteoarticular Infections Working Group of the French Society of Rheumatology, Paris, France Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France PubMed articlesGoogle scholar articles
  • Raphaele Seror Osteoarticular Infections Working Group of the French Society of Rheumatology, Paris, France Rheumatology, Hôpitaux Universitaires Paris-Sud, Le Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Geraldine Bart Rhumatologie, CHU de Rennes, Rennes, France Osteoarticular Infections Working Group of the French Society of Rheumatology, Paris, France PubMed articlesGoogle scholar articles
  • Christelle Darrieutort-Laffite Osteoarticular Infections Working Group of the French Society of Rheumatology, Paris, France Rheumatology, CHU Nantes, Nantes, France INSERM UMR1238, Nantes, France PubMed articlesGoogle scholar articles
  • Benoit Le Goff Osteoarticular Infections Working Group of the French Society of Rheumatology, Paris, France Rheumatology, CHU Nantes, Nantes, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Guillaume Coiffier, Rhumatologie, CHU de Rennes, Rennes 35000, France; guillaume.coiffier{at}chu-rennes.fr
View Full Text

Citation

Coiffier G, Couderc M, Seror R, et al
Is it currently reasonable to offer short, 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?

Publication history

  • Received June 12, 2019
  • Accepted June 17, 2019
  • First published July 5, 2019.
Online issue publication 
October 12, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.